Amplia Therapeutics Financial Overview
Amplia Therapeutics's market cap is currently $43.10M. The company's EPS TTM is $-0.006721; its P/E ratio is -7.75; Amplia Therapeutics is scheduled to report earnings on November 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
